失调
肠道菌群
移植
造血干细胞移植
恶化
移植物抗宿主病
维管菌
免疫学
微生物群
毛螺菌科
干细胞
疾病
医学
造血
内科学
丁酸盐
生物
胃肠病学
链球菌
细菌
生物信息学
发酵
食品科学
厚壁菌
遗传学
16S核糖体RNA
作者
Akihisa Hino,Kentaro Fukushima,Shinsuke Kusakabe,Tomoaki Ueda,Takao Sudo,Jiro Fujita,Daisuke Motooka,Aya Takeda,Natsuko O. Shinozaki,Satoshi Watanabe,Takafumi Yokota,Hirohiko Shibayama,Shota Nakamura,Naoki Hosen
摘要
Dysbiosis of the gut microbiota has been reported to increase early complications after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, it remains unclear whether gut microbial alterations persist during late complications, such as chronic graft-versus-host disease (cGVHD) or secondary cancers. Here, we analysed the gut microbiota of 59 patients who survived for 1-21.7 years (median, 6.4 years) after allo-HSCT. Long-term survivors showed lower gut microbial diversity than the age- and sex-matched healthy controls. This decreased diversity was reflected in the reduced abundance of the butyrate-producing bacteria. Patients with a history of grade 3 acute graft-versus-host disease (aGVHD) exhibited higher Veillonella abundance than patients with a history of grade 1-2 or non-aGVHD cases. The abundance of Faecalibacterium showed no decrease only in limited cGVHD cases. Additionally, the microbial structure in the secondary cancer group was significantly different (p < 0.05) from that in the non-secondary cancer group. This study is the first to show that microbial dysbiosis is present over a 10-year lifetime after discharge following allo-HSCT. Our results suggest that these prolonged gut microbial alterations may be associated with the development and exacerbation of late complications in post-transplant survivors.
科研通智能强力驱动
Strongly Powered by AbleSci AI